SILVERMARS® Phosphorylcholine Coating for Stents

Stents coated with MPC polymer to prevent blood clotting and biofouling. The biocompatible coating mimics human cell membranes, reducing adverse biological reactions and improving device longevity.

Coronary stents with pharmaceutical coating designed to prevent restenosis and promote vessel patency. These devices are used for treatment of coronary artery disease.

Stent systems coated with antiproliferative medications to reduce restenosis rates. Available for coronary and peripheral vessel applications.

Drug-eluting coronary stent system featuring biodegradable polymer coating and optimized elution kinetics for rapid vascular healing. Indicated for percutaneous coronary intervention to restore blood flow in stenosed coronary arteries. The healing-targeted design reduces neointimal proliferation while promoting natural vessel wall healing.

Cardiovascular stent systems designed for coronary and peripheral vascular interventions. The company manufactures stents with advanced coating technologies to reduce restenosis rates. These devices are developed through proprietary research and supported by relevant regulatory certifications.

Specialized stents with controlled drug delivery coatings for sustained release of active pharmaceutical ingredients. Designed to prevent restenosis and maintain vessel patency with optimized clinical performance.

Biomimetic coating utilizing phosphorylcholine zwitterionic properties to improve biocompatibility and prevent thrombosis on implantable and interventional medical device surfaces. Reduces platelet adhesion and blood clotting on coated substrates.

CE-certified Class III coronary stents for percutaneous coronary intervention maintaining vessel patency and preventing restenosis.

Interventional cardiology devices designed to maintain patency in coronary and peripheral vessels. Core product supporting cardiovascular intervention procedures.

Interventional cardiology devices including coronary and peripheral stents designed to restore blood vessel patency and improve coronary blood flow in patients with stenosis.

Precision-manufactured stent devices for vascular intervention and minimally invasive procedures. These devices are designed to maintain vessel patency in cardiovascular applications.

Biomimetic phosphorylcholine coating system for surface modification of implanted and interventional medical devices to enhance biocompatibility and prevent thrombosis in cardiovascular, neurology, dialysis, urinary, respiratory, ophthalmology, and orthopedic applications.